SEC Form 4 · accession 0001144204-15-021418
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Reichling
Officer — CFO
Period of report
Apr 2, 2015
Accepted (ET)
Apr 6, 2015 · 6:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $22.92 | Apr 2, 2015 | A | 3,588 | A | Apr 2, 2016 | Apr 2, 2025 | Common Stock | 3,588 | 219,749 | D |
| Employee Stock Option (right to buy)F1 | $2.98 | holding | — | — | — | Sep 10, 2017 | Sep 10, 2022 | Common Stock | 200,000 | 200,000 | D |
| Employee Stock Option (right to buy) | $14.92 | holding | — | — | — | Feb 26, 2015 | Feb 26, 2024 | Common Stock | 16,161 | 216,161 | D |
Explanation of responses
- F1The option is scheduled for 40% to vest on September 10, 2014, with the remainder vesting pro rata monthly through September 10, 2017.
- F2The option is scheduled to vest on April 2, 2016, the first anniversay of the date of grant.